Flora Natura® Gelée Royale BIO gélules
Food supplement declared in France, decision dated 12 June 2026
Flora Natura® Gelée Royale BIO gélules, from Scientia Natura Distribution, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Gelée royale lyophilisée. None of the rules we check flags an issue with its declared composition.
- Brand
- Flora Natura®
- Food business operator placing the product on the market
- Scientia Natura Distribution
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 2 gélules par jour
- Directions for use
- Prendre 2 gélules par jour.
- Intended populations
- General population
- Objectives stated by the manufacturer (these are not authorised claims)
- Immunity
Declaration 367670, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Gelée royale lyophilisée | not declared |
Additives
E464, E414
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Flora Natura®
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Flora Natura® Gelée Royale BIO gélules: composition and regulation”, https://compoatlas.com/en/supplements/products/367670-flora-natura-gelee-royale-bio-gelules, updated 15 November 2026.